Data / Form D filings / Pulmatrix Operating Company, Inc.
Pulmatrix Operating Company, Inc.: Form D filings
Pulmatrix Operating Company, Inc., a pharmaceuticals company in Lexington, MA, filed 6 Form D notices with the SEC between 2009 and 2015. The latest, on June 30, 2015, reports $1.6 million sold of a $1.6 million offering to 1 investor.
Find out what Pulmatrix Operating Company, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 99 HAYDEN AVENUE, SUITE 390, Lexington, MA, 02421
- Phone
- (781) 357-2333
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1295524
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30, 2015 | New notice | $1,621,422 | $1,621,422 | $0 | 1 | Mar 13, 2015 | sec.gov |
| Jun 30, 2015 | New notice | $34,124,543 | $10,000,000 | $24,124,543 | 11 | Jun 15, 2015 | sec.gov |
| Feb 22, 2013 | Amendment | $24,000,000 | $20,500,000 | $3,500,000 | 11 | Aug 2, 2011 | sec.gov |
| Oct 26, 2012 | Amendment | $17,000,000 | $17,000,000 | $0 | 11 | Aug 2, 2011 | sec.gov |
| Aug 17, 2011 | New notice | $14,000,000 | $5,000,000 | $9,000,000 | 11 | Aug 2, 2011 | sec.gov |
| Nov 2, 2009 | New notice | $30,294,395 | $15,452,728 | $14,841,667 | 10 | Oct 16, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kurt Graves | Director | |
| Steven Gillis | Director | |
| Robert Connelly | Director | |
| Michael Higgins | Director | |
| David Edwards | Director | |
| Terrance McGuire | Director | |
| Robert Clarke | Executive Officer, Director | |
| David Maki | Director | |
| David Hava | Executive Officer | |
| Scott Rocklage | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jun 29, 2015 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Pulmatrix Operating Company, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.